...
首页> 外文期刊>International Journal of Pharmacy and Pharmaceutical Sciences >SPECTROPHOTOMETRIC DETERMINATION OF PROPRANOLOL HYDROCHLORIDE AND METOPROLOL TARTRATE IN PHARMACEUTICAL DOSAGE FORMS, SPIKED WATER AND BIOLOGICAL FLUIDS
【24h】

SPECTROPHOTOMETRIC DETERMINATION OF PROPRANOLOL HYDROCHLORIDE AND METOPROLOL TARTRATE IN PHARMACEUTICAL DOSAGE FORMS, SPIKED WATER AND BIOLOGICAL FLUIDS

机译:分光光度法测定药物剂量配方,食用水和生物液体中盐酸普萘洛尔和异丙基酒石酸根。

获取原文

摘要

Objective : A new spectrophotometric method for the determination of propranolol hydrochloride (PRO) and metoprolol tartrate (MTP), beta blocker drugs, has been developed for their analysis in pharmaceutical dosage forms for the purpose of quality control and water samples for monitoring impact on environmental water quality of natural sources and in biological fluids for ascertaining their physiological performance. Methods: The method is based on the derivatization of the amino function present in these drugs to the corresponding yellow copper (I) drug dithiocarbamate derivative through reaction with carbon disulphide, pyridine and copper (I) perchlorate in aqueous acetonitrile and measuring absorbance at 406 nm for propranolol and 400 nm for metoprolol. The different experimental parameters affecting the development and stability of the colour were carefully studied and optimized. Results: The Beer’s law is obeyed in the range of 1.0-40.0 μg/ml of each drug solution with a correlation coefficient 0.999. The maximum relative standard deviations (RSDs) in the analysis of pure PRO and MTP were 1.01 and 1.52 % respectively. The recoveries of the drugs from pharmaceutical formulations, spiked water samples and biological fluids were in the range 98.0-100.5 % with RSDs in the range 0.23-1.94% indicating good accuracy and precision of the method. Conclusion: The instantaneous development of colour and its stability, well-established stoichiometry of the reaction and above simplicity and rapidity of procedures are some special attributes of the proposed method.
机译:目的:开发了一种用于测定盐酸普萘洛尔(PRO)和酒石酸美托洛尔(MTP)β受体阻滞剂的新分光光度法,用于药物剂型中的分析,以进行质量控制和水样监测对环境的影响天然来源和生物液体中的水质,以确定其生理性能。方法:该方法基于这些药物中存在的氨基官能团通过与二硫化碳,吡啶和高氯酸铜(I)在乙腈水溶液中反应并在406 nm处测量吸光度而衍生为相应的黄色铜(I)药物二硫代氨基甲酸酯衍生物。用于普萘洛尔,400 nm用于美托洛尔。仔细研究和优化了影响颜色显影和稳定性的不同实验参数。结果:每种药物溶液的比尔定律在1.0-40.0μg/ ml的范围内,相关系数为0.999。在纯PRO和MTP分析中,最大相对标准偏差(RSD)分别为1.01和1.52%。从药物制剂,加标水样和生物液体中回收的药物的回收率在98.0-100.5%范围内,RSD在0.23-1.94%的范围内,表明该方法具有良好的准确性和准确性。结论:颜色的瞬时发展及其稳定性,反应的良好化学计量以及操作的简便性和快速性是该方法的一些特殊属性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号